School & Graduate Institute of Physical Therapy, College of Medicine, NTU
Taipei, 100, Taiwan
NCT Number: NCT03880630
Background & Objective: Inspiratory muscle training (IMT) is known to improve strength and endurance of inspiratory muscles. However, clinical beneficial effects of IMT for patients with chronic respiratory disease remain inconclusive.
The purposes of the study are to investigate in patients with chronic respiratory disease: (Year 1) main (diaphragm) and accessory inspiratory muscle (sternocleidomastoid muscle) activation pattern during various IMT loading using group-based trajectory modeling (GBTM); and (Year 2) effectiveness of individualized IMT program (based on results of Year 1) on clinical outcomes. Methods: (Year 1) Patients with chronic respiratory disease with inspiratory muscle weakness will be recruited for the study. Patients will perform 3 inspiratory loading tests (15%, 30%, and 50% of maximum inspiratory pressures) on 3 separate days with the sequence will be randomized. Surface electromyography (EMG) of diaphragm and sternocleidomastoid muscle will be used to use inspiratory muscle activation during various conditions. Other outcomes include maximum inspiratory pressure, and functional exercise capacity will be measured. Inspiratory muscle activation will be used for GBTM analysis. Patient will then be trained with individualized IMT program based on the GBTM analysis input form results of Year 1.
Looking for future studies?
Notify Me20 year and older
All sexes
Interventional
Not applicable
Taipei, 100, Taiwan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will perform 3 inspiratory loading tests (15%, 30%, and 50% of maximum inspiratory pressures) on 3 separate days with the sequence will be randomized. Patient will then be trained with individualized IMT program based on the results of 3 inspiratory loading tests.
Time frame: through the completion of the inspiratory loading tests condition; it would take about 3 minutes
Root mean square values during different conditions
Time frame: In five minute after the completion of the loaded inspiratory muscle test condition
The power spectrum is divided into two equal areas of the frequency value by median frequency to exam muscle fatigability
Time frame: About five minutes to complete
Forced expiratory volume in one second, forced vital capacity, residual volume, total lung capacity
Time frame: About three minutes to complete
Maximal inspiratory pressure
Time frame: The six-minute walk test needs six minute to complete the test
The six-minute walk test is commonly performed to evaluate functional exercise capacity. The six-minute walk test was performed according to the guidelines, and the distance walked in the test presented as functional exercise capacity
Time frame: The six-minute walk test needs six minute to complete the test
Heart rate is measured at rest, during six-minute walk test
Time frame: Before and immediately after the six-minute walk test;it takes less than one minute to measure blood pressure
systolic and diastolic pressure are measured at rest, after six-minute walk test
Time frame: It takes less than one minute to evaluate perceived dyspnea
Rating of perceived dyspnea is measured by using Borg scale at rest, during six-minute walk test, inspiratory loading tests. The most widely used tool is the "Borg scale", with rating ranges from 0 (nothing at all) to 10 (extremely dyspnea).
Time frame: The six-minute walk test needs six minute to complete the test; through the completion of the inspiratory loading tests condition; it would take about 3 minutes
Oxygen saturation is continuously monitored by pulse oximetry throughout six-minute walk test, inspiratory loading tests
National Taiwan University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06149494
COPD, COPD Exacerbation Acute
London, United Kingdom
View Trial DetailsNCT04911764
Behavior, COPD
Limoges, France
View Trial DetailsNCT04711057
Behavior, Chronic Disease
Aveiro, Portugal
View Trial DetailsNCT05852821
Chronic Respiratory Disease
Lodève, France
View Trial Details